253 related articles for article (PubMed ID: 35291561)
1.
Montagne A; Nikolakopoulou AM; Huuskonen MT; Sagare AP; Lawson EJ; Lazic D; Rege SV; Grond A; Zuniga E; Barnes SR; Prince J; Sagare M; Hsu CJ; LaDu MJ; Jacobs RE; Zlokovic BV
Nat Aging; 2021 Jun; 1(6):506-520. PubMed ID: 35291561
[TBL] [Abstract][Full Text] [Related]
2. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
Montagne A; Nation DA; Sagare AP; Barisano G; Sweeney MD; Chakhoyan A; Pachicano M; Joe E; Nelson AR; D'Orazio LM; Buennagel DP; Harrington MG; Benzinger TLS; Fagan AM; Ringman JM; Schneider LS; Morris JC; Reiman EM; Caselli RJ; Chui HC; Tcw J; Chen Y; Pa J; Conti PS; Law M; Toga AW; Zlokovic BV
Nature; 2020 May; 581(7806):71-76. PubMed ID: 32376954
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.
Bell RD; Winkler EA; Singh I; Sagare AP; Deane R; Wu Z; Holtzman DM; Betsholtz C; Armulik A; Sallstrom J; Berk BC; Zlokovic BV
Nature; 2012 May; 485(7399):512-6. PubMed ID: 22622580
[TBL] [Abstract][Full Text] [Related]
4. Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.
Halliday MR; Rege SV; Ma Q; Zhao Z; Miller CA; Winkler EA; Zlokovic BV
J Cereb Blood Flow Metab; 2016 Jan; 36(1):216-27. PubMed ID: 25757756
[TBL] [Abstract][Full Text] [Related]
5. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
[TBL] [Abstract][Full Text] [Related]
6. Little genomic support for Cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers.
Anderson EL; Williams DM; Walker VM; Davies NM
Sci Rep; 2022 Jan; 12(1):1057. PubMed ID: 35058547
[TBL] [Abstract][Full Text] [Related]
7. ApoE4-mediated blood-brain barrier damage in Alzheimer's disease: Progress and prospects.
Zhou X; Shi Q; Zhang X; Gu L; Li J; Quan S; Zhao X; Li Q
Brain Res Bull; 2023 Jul; 199():110670. PubMed ID: 37224887
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
[TBL] [Abstract][Full Text] [Related]
9. A "multi-omics" analysis of blood-brain barrier and synaptic dysfunction in APOE4 mice.
Barisano G; Kisler K; Wilkinson B; Nikolakopoulou AM; Sagare AP; Wang Y; Gilliam W; Huuskonen MT; Hung ST; Ichida JK; Gao F; Coba MP; Zlokovic BV
J Exp Med; 2022 Nov; 219(11):. PubMed ID: 36040482
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
11. Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits.
Belinson H; Lev D; Masliah E; Michaelson DM
J Neurosci; 2008 Apr; 28(18):4690-701. PubMed ID: 18448646
[TBL] [Abstract][Full Text] [Related]
12. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
[TBL] [Abstract][Full Text] [Related]
13. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
14. Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes.
Blanchard JW; Bula M; Davila-Velderrain J; Akay LA; Zhu L; Frank A; Victor MB; Bonner JM; Mathys H; Lin YT; Ko T; Bennett DA; Cam HP; Kellis M; Tsai LH
Nat Med; 2020 Jun; 26(6):952-963. PubMed ID: 32514169
[TBL] [Abstract][Full Text] [Related]
15. Modeling Mixed Vascular and Alzheimer's Dementia Using Focal Subcortical Ischemic Stroke in Human ApoE4-TR:5XFAD Transgenic Mice.
Hayden EY; Huang JM; Charreton M; Nunez SM; Putman JN; Teter B; Lee JT; Welch A; Frautschy S; Cole G; Teng E; Hinman JD
Transl Stroke Res; 2020 Oct; 11(5):1064-1076. PubMed ID: 32086779
[TBL] [Abstract][Full Text] [Related]
16. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
[TBL] [Abstract][Full Text] [Related]
17. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.
Hartman RE; Laurer H; Longhi L; Bales KR; Paul SM; McIntosh TK; Holtzman DM
J Neurosci; 2002 Dec; 22(23):10083-7. PubMed ID: 12451108
[TBL] [Abstract][Full Text] [Related]
19. Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction.
Marottoli FM; Katsumata Y; Koster KP; Thomas R; Fardo DW; Tai LM
ASN Neuro; 2017; 9(4):1759091417719201. PubMed ID: 28707482
[TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease.
Zlokovic BV
JAMA Neurol; 2013 Apr; 70(4):440-4. PubMed ID: 23400708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
